Literature DB >> 1423394

Gianturco self-expanding stents: clinical experience in the vena cava and large veins.

J D Irving1, R F Dondelinger, J F Reidy, H Schild, R Dick, A Adam, M Maynar, C L Zollikofer.   

Abstract

Twenty-five patients with stenosis of the vena cava (21) and other large veins (4) have been treated with self-expanding Gianturco metallic stents. Eighteen patients had superior vena cava syndrome. In 17, the stricture was due to malignant superior vena cava compression recurrent after maximum tolerance radiotherapy and/or chemotherapy. In 16 of these patients there was early symptomatic relief. In 1 patient with a benign posttraumatic superior vena cava stricture, the stenosis was not relieved, and occlusion occurred after 1 month. Stenoses associated with dialysis shunts were relieved in 2 other patients. Two malignant and one benign inferior vena cava stenoses were relieved either until death, or in the benign case, for 30 months. One malignant subclavian vein obstruction occluded after 24 h due to stent misplacement and another with extrinsic mediastinal compression remained patent until death, extensive thrombus having been lysed prior to stent placement. The results of this short series suggest that the Gianturco self-expanding stent in the vena cava and large veins is easy and safe to place, and in most cases produces almost immediate palliation of the distressing effects of venous obstruction, often in a preterminal and inoperable patient.

Entities:  

Mesh:

Year:  1992        PMID: 1423394     DOI: 10.1007/bf02733958

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  16 in total

1.  Venous stenoses in dialysis shunts: treatment with self-expanding metallic stents.

Authors:  R W Günther; D Vorwerk; K Bohndorf; K C Klose; D Kistler; H Mann; H G Sieberth; A el-Din
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

2.  Superior vena cava syndrome associated with massive thrombosis: treatment with expandable wire stents.

Authors:  J S Putnam; B T Uchida; R Antonovic; J Rösch
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

3.  Superior vena cava syndrome. Clinical management.

Authors:  R Goodman
Journal:  JAMA       Date:  1975-01-06       Impact factor: 56.272

4.  Management of superior vena cava syndrome.

Authors:  C A Perez; C A Presant; A L Van Amburg
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

5.  Endovascular stenting of veins and grafts: preliminary clinical experience.

Authors:  C L Zollikofer; I Largiader; W F Bruhlmann; G K Uhlschmid; A H Marty
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

6.  Tracheobronchial tree: expandable metallic stents used in experimental and clinical applications. Work in progress.

Authors:  M J Wallace; C Charnsangavej; K Ogawa; C H Carrasco; K C Wright; R McKenna; M McMurtrey; C Gianturco
Journal:  Radiology       Date:  1986-02       Impact factor: 11.105

7.  Gianturco expandable wire stents in the treatment of superior vena cava syndrome recurring after maximum-tolerance radiation.

Authors:  J Rösch; J E Bedell; J Putnam; R Antonovic; B Uchida
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

8.  Gianturco expandable metallic biliary stents: results of a European clinical trial.

Authors:  J D Irving; A Adam; R Dick; R F Dondelinger; A Lunderquist; A Roche
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

Review 9.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Operative treatment of refractory superior vena cava syndrome.

Authors:  M A Gutowicz; W J Quinones-Baldrich; C P Lieber; D V Pecora
Journal:  Am Surg       Date:  1984-07       Impact factor: 0.688

View more
  15 in total

1.  Stent-graft in the management of superior vena cava syndrome.

Authors:  D H Chin; B D Petersen; H Timmermans; J Rösch
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jul-Aug       Impact factor: 2.740

2.  Wallstent endovascular prosthesis for the treatment of superior vena cava syndrome.

Authors:  S Sasano; T Onuki; M Mae; K Oyama; M Sakuraba; S Nitta
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-03

Review 3.  Palliative procedures in lung cancer.

Authors:  Emi Masuda; Akhilesh K Sista; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

4.  Successful iliac vein and inferior vena cava stenting ameliorates venous claudication and improves venous outflow, calf muscle pump function, and clinical status in post-thrombotic syndrome.

Authors:  Konstantinos T Delis; Haraldur Bjarnason; Paul W Wennberg; Thom W Rooke; Peter Gloviczki
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

Review 5.  Stenting of superior vena caval obstruction.

Authors:  J E Jackson; D M Brooks
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

6.  Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent.

Authors:  K W Stock; A L Jacob; M Proske; C T Bolliger; C Rochlitz; W Steinbrich
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

7.  Expandable Wallstent for the treatment of obstruction of the superior vena cava.

Authors:  A F Watkinson; D M Hansell
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

8.  Stenosis of the inferior vena cava after liver transplantation: treatment with Gianturco expandable metallic stents.

Authors:  G Simó; A Echenagusia; F Camúñez; P Quevedo; I J Calleja; J P Ferreiroa; R Bañares
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jul-Aug       Impact factor: 2.740

Review 9.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02

10.  Percutaneous management of superior vena cava occlusions.

Authors:  M T Crowe; C H Davies; P A Gaines
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.